Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04347967 |
|
Recruitment Status :
Not yet recruiting
First Posted : April 15, 2020
Last Update Posted : March 20, 2023
|
Sponsor:
Meridigen Biotech Co., Ltd.
Information provided by (Responsible Party):
Meridigen Biotech Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | September 2024 |
| Estimated Study Completion Date : | September 2025 |